Biofrontera AG (ETR:B8FK)
Germany
· Delayed Price · Currency is EUR 2.550
-0.060 (-2.30%)
At close: May 12, 2025, 5:30 PM CET
Biofrontera AG Revenue
In the year 2024, Biofrontera AG had annual revenue of 21.67M EUR, down -32.81%. Biofrontera AG had revenue of 10.94M in the quarter ending December 31, 2024, with 46.89% growth.
Revenue
21.67M
Revenue Growth
-32.81%
P/S Ratio
0.72
Revenue / Employee
246.20K
Employees
88
Market Cap
15.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.67M | -10.58M | -32.81% |
| Dec 31, 2023 | 32.25M | 6.51M | 25.29% |
| Dec 31, 2022 | 25.74M | -3.05M | -10.59% |
| Dec 31, 2021 | 28.79M | -1.56M | -5.14% |
| Dec 31, 2020 | 30.35M | -919.00K | -2.94% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 76.54B |
| Deutsche Telekom AG | 118.43B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Merck KGaA | 21.16B |